Results 21 to 30 of about 32,366 (248)

Profiling risk factors for chronic uveitis in juvenile idiopathic arthritis: a new model for EHR-based research. [PDF]

, 2013
BackgroundJuvenile idiopathic arthritis is the most common rheumatic disease in children. Chronic uveitis is a common and serious comorbid condition of juvenile idiopathic arthritis, with insidious presentation and potential to cause blindness. Knowledge
Bauer-Mehren, Anna, Cole, Tyler S, Frankovich, Jennifer, Iyer, Srinivasan, Lependu, Paea, Shah, Nigam H   +5 more
core   +3 more sources

EFFICACY OF ETANERCEPT IN TREATMENT OF VARIOUS TYPES OF JUVENILE IDIOPATHIC ARTHRITIS

Вопросы современной педиатрии, 2013
Aim: to assess efficacy and safety of etanercept in treatment of various types of juvenile idiopathic arthritis in children under conditions of real clinical practice.
O. Yu. Konopel'ko, E. S. Zholobova, M. N. Nikolaeva, O. S. Rozvadovskaya, V. Ya. El'yashevich, E. Yu. Afonina   +5 more
doaj   +1 more source

Review of International Registers of Patients with Systemic Juvenile Idiopathic Arthritis

Вопросы современной педиатрии, 2017
The article describes the international experience in monitoring of patients with juvenile idiopathic arthritis. The main goal of most existing international registers of children with juvenile idiopathic arthritis is to evaluate various aspects of the ...
Ekaterina I. Alekseeva, Olga L. Lomakina, Saniya I. Valieva, Tatiana M. Bzarova   +3 more
doaj   +1 more source

Protocol for the Foot in Juvenile Idiopathic Arthritis trial (FiJIA): a randomised controlled trial of an integrated foot care programme for foot problems in JIA [PDF]

, 2009
<b>Background</b>: Foot and ankle problems are a common but relatively neglected manifestation of juvenile idiopathic arthritis. Studies of medical and non-medical interventions have shown that clinical outcome measures can be improved ...
A Manca, A Mavidrou, A Premkumar, B Karmazyn, CA Wallace, DD Sherry, DE Turner, Deborah E Turner, Department of Health, DG Altman, E Brostrom, E Filippucci, EGL Bywaters, EH Giannini, G Hendry, G Singh, G Spaul, GF Watt, Gordon F Watt, Gordon J Hendry, HE Foster, HE Foster, J Coast, J Ferrari, J Thornton, Janet Gardner-Medwin, JF Fries, Jim Woodburn, JJ Louviere, John McColl, KJ Murray, L Curtis, Lorraine Friel, M Andre, M Arkela-Kautiainen, M Powell, M Ryan, M Szkudlarek, MA D'Agostino, Medical Research Council Health Services and Public Health Research Board Report, Michael Browne, MJ Platto, MM Steven, N Adib, NW Scott, P Dolan, P Tynjala, Paula K Lorgelly, PJ Manners, PS Fairburn, PS Helliwell, R Brooks, R Burgos-Vargas, RE Petty, Roger D Sturrock, S Barnatsky, S Magni-Manzoni, T Beukelman, TB Graeme, W Grassi, YM El-Miedany   +60 more
core   +4 more sources

Neutralization of IFN-γ reverts clinical and laboratory features in a mouse model of macrophage activation syndrome. [PDF]

, 2018
BACKGROUND: The pathogenesis of macrophage activation syndrome (MAS) is not clearly understood: a large body of evidence supports the involvement of mechanisms similar to those implicated in the setting of primary hemophagocytic lymphohistiocytosis ...
Bracaglia, Claudia, Caiello, Ivan, Chatel, Laurence, De Min, Cristina, Fabrizio De Benedetti, And, Ferlin, Walter G., Grom, Alexei A., Marasco, Emiliano, Pascarella, Antonia, Prencipe, Giusi, Strippoli, Raffaele   +10 more
core   +1 more source

CLINICAL CASE OF TOCILIZUMAB THERAPY IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

Педиатрическая фармакология, 2013
The article presents a case of successful application of a monoclonal antibodies drug to interleukin 6 receptors (tocilizumab) at severe systemic juvenile idiopathic arthritis with the development of secondary hemophagocytic syndrome.
E. I. Alexeeva, E. I. Alexeeva, R. V. Denisova, T. V. Sleptsova   +3 more
doaj   +1 more source

Systemic Onset Juvenile Idiopathic Arthritis [PDF]

Journal of Stress Physiology & Biochemistry, 2023
Systemic onset juvenile idiopathic arthritis, systemic JIA, sJIA, is a disease that develops before the age of 16 years and is active for at least 6 weeks.
Kolesnichenko A.A., Vasilyeva I.V.
doaj  

Nuclear matrix protein 2 antibody-positive adult dermatomyositis: a case report and review of the literature [PDF]

, 2020
Dermatomyositis is a clinically heterogenous inflammatory myopathy with unique cutaneous features. Myositis-specific antibodies can aid in diagnosis and anticipation of patient prognosis.
Cartron, Alexander M, Chung, Catherine, Osler, Montana, Trinidad, John C   +3 more
core  

Vitamin D supplementation in the pediatric rheumatology clinic. [PDF]

, 2011
Vitamin D is capturing the attention of healthy and chronically ill populations for its potential skeletal and nonskeletal benefits. New information suggesting a role in immune modulation has led to a surge of interest among rheumatologists. Although the
Burnham, Jon M, von Scheven, Emily
core   +3 more sources

Macrophage activation syndrome in a patient with systemic onset of the juvenile idiopathic arthritis

Rheumatology, 2016
Systemic onset juvenile idiopathic arthritis (sJIA) is defined as arthritis affecting one or more joint usually in the juvenile age group (< 16 years of age) with or preceded by fever of at least 2 weeks duration that is documented to be daily ...
Deepak Jain, Hari K. Aggarwal, Avinash Rao, Anshul Mittal, Promil Jain   +4 more
doaj   +1 more source